Concord Biotech Limited (BOM:543960)
India flag India · Delayed Price · Currency is INR
2,013.45
+86.20 (4.47%)
At close: Jun 9, 2025

Concord Biotech Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
Cash & Equivalents
11.83151.4234.996.6751.44
Upgrade
Short-Term Investments
3,165228.22305.8872.5550
Upgrade
Trading Asset Securities
-2,4371,369734.731,410
Upgrade
Cash & Short-Term Investments
3,1772,8171,7101,6142,011
Upgrade
Cash Growth
12.80%64.71%5.96%-19.76%0.31%
Upgrade
Accounts Receivable
5,2173,4962,7382,3221,775
Upgrade
Other Receivables
-159.99217.95272.74358.19
Upgrade
Receivables
5,2173,6562,9562,5942,133
Upgrade
Inventory
2,3972,0802,1231,9511,536
Upgrade
Prepaid Expenses
-73.3155.1947.6145.44
Upgrade
Other Current Assets
561.96336.73433.05119.5345.27
Upgrade
Total Current Assets
11,3528,9627,2776,3276,071
Upgrade
Property, Plant & Equipment
8,4427,8657,6556,4365,577
Upgrade
Long-Term Investments
187.2620.779.252.563.66
Upgrade
Other Intangible Assets
11.223.21.9835.7764.18
Upgrade
Other Long-Term Assets
349.41156.1126.8327.4108.69
Upgrade
Total Assets
20,34317,00715,14013,12811,825
Upgrade
Accounts Payable
1,130944.35938831.06463.97
Upgrade
Accrued Expenses
-168.21146.19131.45102.38
Upgrade
Short-Term Debt
---43.3750.99
Upgrade
Current Portion of Long-Term Debt
3.8162.3250250250
Upgrade
Current Portion of Leases
19.5816.211.4715.9613.01
Upgrade
Current Income Taxes Payable
101.2754.9489.99--
Upgrade
Current Unearned Revenue
--13.1332.72-
Upgrade
Other Current Liabilities
585.57175.55479.67247.1177.04
Upgrade
Total Current Liabilities
1,8411,4221,9181,5521,057
Upgrade
Long-Term Debt
--62.36312.49562.5
Upgrade
Long-Term Leases
6.318.871.643.1116.33
Upgrade
Long-Term Deferred Tax Liabilities
340.22280.65234.39209.71174.53
Upgrade
Other Long-Term Liabilities
28.219.5622.9718.7420.98
Upgrade
Total Liabilities
2,2151,7412,2402,0961,832
Upgrade
Common Stock
104.62104.62104.6295.1195.11
Upgrade
Additional Paid-In Capital
-819.71819.71829.22829.22
Upgrade
Retained Earnings
-14,34211,97610,1089,069
Upgrade
Comprehensive Income & Other
18,023----
Upgrade
Shareholders' Equity
18,12715,26612,90011,0329,994
Upgrade
Total Liabilities & Equity
20,34317,00715,14013,12811,825
Upgrade
Total Debt
29.6997.38315.46624.93892.83
Upgrade
Net Cash (Debt)
3,1482,7191,395988.981,118
Upgrade
Net Cash Growth
15.75%94.98%41.02%-11.58%-24.66%
Upgrade
Net Cash Per Share
30.0825.9913.339.4510.69
Upgrade
Filing Date Shares Outstanding
104.61104.62104.62104.62104.62
Upgrade
Total Common Shares Outstanding
104.61104.62104.62104.62104.62
Upgrade
Working Capital
9,5127,5415,3594,7755,014
Upgrade
Book Value Per Share
173.28145.93123.31105.4595.53
Upgrade
Tangible Book Value
18,11615,26312,89810,9969,930
Upgrade
Tangible Book Value Per Share
173.18145.90123.29105.1194.91
Upgrade
Land
-547.11547.11547.11546.99
Upgrade
Buildings
-2,5762,4632,2261,981
Upgrade
Machinery
-4,9794,7884,2853,773
Upgrade
Construction In Progress
-2,1151,727741.55179.46
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.